Introduction
Aspergillus fumigatus is an airborne fungus that causes a range of disease states in humans (summarized in Table 1 ) [1] . Exposure to inhaled spores (conidia) is lifelong and, for most humans, symptomless. Invasive disease occurs in hosts with defects in myeloid cell number or function and results from spore germination into tissue-invasive hyphae. Allergenic disease can develop in hosts with underlying inflammatory conditions, exemplified by asthma, atopy, and cystic fibrosis, and arises from dysregulated or exuberant immune responses to fungal antigens in colonized airways.
Following A. fumigatus spore inhalation, the respiratory immune system initiates a series of events that culminates in fungal clearance in immune-competent hosts. These include fungal particle recognition, uptake by opsonic and nonopsonic receptors, killing by reactive oxygen-dependent and oxygen-independent mechanisms, and the release of mediators that coordinate effector cell recruitment, activation, and function in the innate and adaptive phases of the response (for comprehensive reviews see [1, 2] ). Damage to host tissue can occur with unrestrained fungal growth or from the recruitment of inflammatory cells to infected sites. Although humans represent accidental hosts for airborne A. fumigatus spores, fungal attributes that have evolved for survival in its ecologic niche (decaying organic matter) can act to counter clearance mechanisms at distinct steps listed above and promote fungal pathogenesis and persistence in hostile tissue environments [3, 4] .
The fungal cell wall: the center of discourse
The fungal cell wall has a significant impact on the host immune response as it represents the first structure encountered by the host cells and contains a number of polysaccharides with immune activating and modulatory properties; these include b-1,3/1,4-glucan, a-1,3glucan, chitin, galactomannan, and a unique polymer of galactosaminogalactan [5 -7] . Fungal cell wall composition varies during the process of germination and hyphal growth and is influenced by the presence of antifungal drugs and local conditions in tissue microenvironments.
The surface of inhaled spores contains a proteinaceous layer that masks the underlying immunologically active polysaccharides [8 ] . At this stage, a critical opsonic interaction is the binding of the collectin pentraxin-3, released primarily from neutrophil granules, to the spore surface [9] . Pentraxin-3 (À/À) mice are vulnerable to A. fumigatus infection [10] , and this susceptibility has been associated with a defect in spore uptake, as neutrophils take up pentraxin-3-coated spores much more efficiently than uncoated spores. Pentraxin-3-dependent fungal cell uptake operates via a complement protein C3-dependent process that involves CD11b (CR3) and FcgR recruitment to the phagocytic cup. The protective function of pentraxin-3 administration is abolished in FcgR (À/À) mice but not in SCID and Rag-2 (À/À) mice, excluding a role for antibody in pentraxin-3-dependent and FcRgdependent spore uptake process [11 ] . Pentraxin-3 can also act as an endogenous inhibitor of neutrophil adhesion to vascular surfaces by binding to endothelial P-selectin [12] . Whether this regulatory mechanism is beneficial during respiratory fungal infection remains unclear, but may serve to limit inflammation-induced tissue damage.
A. fumigatus can counter opsonization and complement activation through secreted proteolytic activity. The alkaline protease Alp1 degrades human complement proteins C3, C4, and C5 [13] . Although the virulence of the Dalp1 strain is similar to the wild-type strain in a pulmonary infection model [13] , another study found that the complement-degrading proteolytic activity diminishes fungal uptake by brain microglial cells [14] , suggesting a possible role in the pathogenesis of disseminated CNS aspergillosis.
Diverse signaling receptors recognize cell wall changes during germination
The process of spore swelling, the first step of germination, results in the obligate exposure of fungal ligands that bind cognate C-type lectin (CTL) and Toll-like receptors (TLRs) [1, 2, 15] . This process activates signaling pathways linked to the production of inflammatory cytokines and chemokines, prostaglandins, as well as the production of reactive oxygen. Germination is associated with an increase in fungal metabolism, which is important for the production of immunomodulatory factors such as primary and secondary metabolites and the secreted protease mentioned above. Chief among these host-fungal 316 Infections of the immunocompromised host
Key points
Dissecting the molecular mechanisms of Aspergillus fumigatus recognition in the lung has identified critical antifungal effector pathways and established that human genetic variants confer risk for invasive disease during hematopoietic stem cell transplantation. Monocytes, dendritic cells, and natural killer cells play important roles in A. fumigatus host defense and may be of particular significance in neutropenic patients.
The formation of specific CD4 T-cell effector populations during invasive and allergenic disease depends in part on Toll-like receptor and C-type lectin signaling pathways in innate cells recruited to the lung. Understanding fungal metabolic pathways that are activated in hostile tissue microenvironments and in response to antifungal therapy point to novel microbial targets for drug development and a better understanding of the role of immunomodulatory therapies in these settings. interactions is the binding of the CTL receptor Dectin-1 to fibrillar b-(1,3)-glucan [16] [17] [18] . Dectin-1 (À/À) mice are more susceptible to high doses of A. fumigatus than control mice and produce diminished proinflammatory cytokine responses [19] . In allogeneic stem cell transplant patients, receipt of a T-cell-depleted allograft that contains a defective Dectin-1 allele (Dectin-1 Y238X/þ ) is associated with an increased risk of developing invasive aspergillosis [20 ] .
TLR2, TLR4, and TLR9 are implicated in A. fumigatus recognition and signaling through the common TLR adaptor protein MyD88 [1] . MyD88 (À/À) mice exhibit a higher lung fungal burden than control mice and mount dysregulated inflammatory responses [21] . In humans, the presence of a TLR4 polymorphism among donor cells increases the risk for invasive aspergillosis among hematopoietic stem cell transplant (HCT) recipients [22] . Thus, both Dectin-1-dependent and MyD88-dependent signals are crucial for host defense in mice and humans.
Germinating spores and hyphae also trigger interelukin (IL)-1b release by a macrophage cell line [23] and in vivo [19] . Gene-silencing experiments implicate the NRLP3 inflammasome in caspase-1 activation [23] . The precise in-vivo role of the NLRP3 inflammasome and IL-1 signaling in host defense remains undefined, though downstream IL-1 receptor-dependent pathways may not be essential for survival [24] .
New players on the block: traps, monocytes, and natural killer cells
Although neutrophil-mediated spore and hyphal killing is essential to defense [1] , recent work indicates that other inflammatory cell populations, notably monocytes, dendritic cells, and natural killer (NK) cells, exert direct antifungal effector properties and, in the case of infection-induced dendritic cells, initiate the adaptive phase of the immune response.
Neutrophil extracellular traps
Beyond established effector mechanisms (reactive oxygen, phagosome proteolytic activity, and granule proteins such as lactoferrin), neutrophils can form extracellular traps upon encountering germinating A. fumigatus spores and hyphae in the test tube and lung [25, 26] . Although their relative role in fungal killing remains unknown, Neutrophil extracellular trap formation was restored by gene therapy in a patient with chronic granulomatous disease and coincided with the resolution of preexisting pulmonary aspergillosis [27] .
Role of monocytes, dendritic cells, and natural killer cells in host defense
The murine lung inflammatory cell infiltrate contains numerous Ly6C hi monocytes (also known as inflamma-tory monocytes) recruited from bone marrow stores via CC chemokine receptor 2 (CCR2)-mediated mechanisms within 24 h postinfection ( Fig. 1 ) [28 ] . Human CD14 þ monocytes, murine Ly6C hi monocyte counterparts, phagocytose spores and inhibit germination [29] . In infected lungs, Ly6C hi monocytes rapidly differentiate into CD11b þ CD11c þ MHC class II hi monocyte-derived dendritic cells (Mo-DCs) and transport spores to lungdraining lymph nodes, a process that is essential for the priming and expansion of A. fumigatus-specific CD4 T cells [28 ] .
The size of the lung Mo-DC population correlates with survival in neutropenic mice [30 ] and is greater in neutropenic than in neutrophil-sufficient animals, even when mice are challenged with killed fungal products [31 ] . In neutropenic mice, monocyte-dependent and Mo-DC-dependent tumor necrosis factor production enhances their CCR2-dependent pulmonary trafficking [31 ] . Genetic deletion of the chemokine receptor CCR7 in hematopoietic cells enhances Mo-DC production from bone marrow precursors following bone marrow transplantation [32] and diminishes Mo-DC lung egress to draining lymph nodes [30 ] , both of which increase the number of Mo-DCs in infected lungs and correlate with enhanced survival. Depletion strategies that predominately target monocytes and Mo-DCs in immune-competent mice (using ablation of CCR2 þ cells) or that include Mo-DCs in neutropenic mice (using ablation of CD11c þ cells) result in delayed fungal clearance [28 ] or in diminished survival [31 ] .
A recent study found a role for plasmacytoid dendritic cells during respiratory fungal infection [33] . Purified plasmacytoid dendritic cells damage A. fumigatus hyphae in a partially Zn 2þ -dependent mechanism that is consistent with a role for the granular protein calprotectin in fungal cell killing. Furthermore, mice defective in type I interferon production are susceptible to invasive disease. The finding that antibody-mediated plasmacytoid dendritic cell depletion recapitulates this phenotype, albeit in a milder form, is consistent with a role for plasmacytoid dendritic cell-dependent type I interferon production in host defense in vivo.
In neutropenic mice, the recruitment or adoptive transfer of NK cells to infected lungs is beneficial [34] . NK-cellderived interferon (IFN)-g activates macrophage-dependent fungal clearance in vitro and is essential for NK-celldependent host defense in neutropenic mice in vivo [35] .
In-vitro studies demonstrate that human NK cells damage A. fumigatus hyphae [36] . Thus, a key translational question is to define a therapeutic role for NK cells, monocytes, and dendritic cells as effector cells in diseased patients, particularly as these cells can be harvested by leukopheresis and expanded ex vivo.
Aspergillus fumigatus-specific CD4 T cells
A. fumigatus spore exposure leads to the development of diverse CD4 T-cell responses that include T helper (Th) 1, Th2, Th17, and regulatory T (Treg) cells [37] . Protection against invasive aspergillosis in mice [38, 39] and humans [40] relies in part on fungus-specific CD4 T cells. In immune compromised patients, adoptive transfer of A. fumigatus-specific CD4 T cells can provide a benefit [41, 42] . Consistent with the notion that Th1 responses are beneficial, neutralizing Th2-biased cytokines in neutropenic mice improves disease outcome [38] .
Various factors contribute to the molecular and cellular mechanisms that regulate A. fumigatus-specific CD4 Tcell differentiation toward Th1, Th2, and Th17 effector cells in vivo. These include exposure frequency, antigen type, engagement of CTL and TLR signaling pathways, and infection-induced dendritic cell populations in the lung. In single exposure models, the A. fumigatus-specific CD4 T-cell airway response consists of a dominant Th1 and a smaller Th17 population [43 ,44] . Similarly, CD4 T-cell responses in healthy individuals are primarily Th1-biased [45] , whereas A. fumigatus-specific Th2 CD4 T cells predominate in the response in allergic bronchopulmonary aspergillosis (ABPA) patients and contribute to disease progression [46 ] . Repeated exposures to A. fumigatus spores in murine pulmonary infection models result in increased recruitment of Th2 and Th17 CD4 T cells [47] . In a vaccine model, distinct preparations of A. fumigatus antigens induce the selective expansion of various CD4 T-cell subsets with secreted antigens promoting the differentiation of Th2 cells, membrane components Th1 cells, and glycolipids Th17 cells [37] . Similarly, the protease activity of A. fumigatus allergens is crucial to their capacity to induce Th2 differentiation [48] .
Role of Dectin-1 and Toll-like receptor signaling on the formation of fungus-specific CD4 effector cells
The induction of predominately Th1-or Th2-biased CD4 T-cell responses by live and heat-inactivated spores, respectively, indicates that innate receptor signaling activated by the process of spore germination is a critical determinant of CD4 T cell differentiation [49] . Innate TLR-MyD88 signaling is crucial for the initial induction of T-bet (Th1 transcription factor) in the lungdraining lymph node, while MyD88-independent and Dectin-1-independent mechanisms promote further Tbet expression in CD4 T cells that enter airways [43 ,44] . In turn, the induction of T-bet expression in fungus-specific CD4 T cells inhibits Th17 differentiation [43 ] , consistent with a role of T-bet in suppressing RORgt (Th17 transcription factor) induction [50] and similar to its known role in suppressing GATA-3 (Th2 transcription factor) induction [51, 52] . Thus, T-bet expression is a critical switch in the regulation of A. fumigatus-specific CD4 T-cell differentiation.
Following A. fumigatus infection, Dectin-1 signaling and the presence of Mo-DCs influence T-bet expression levels in fungus-specific CD4 T cells. Dectin-1 signals act on innate cells to diminish the production of IL-12p35 and IFN-g, leading to a reduction in T-bet expression by fungus-specific CD4 T cells. By regulating T-bet expression levels in CD4 T cells, Dectin-1 facilitates the development of Th17 effector cells and contributes to the establishment of a more diverse CD4 T-cell response [43 ] .
Beyond their role in fungal antigen transport to lungdraining lymph nodes, monocyte derivatives provide essential cues that shape CD4 T-cell differentiation [43 ] . Depletion of Mo-DCs at various times after infection results in enhanced Th17 and diminished Th1 differentiation. The alteration in the Th1/Th17 balance correlates with a loss of T-bet expression in fungusspecific CD4 T cells. Thus, it appears that monocyte derivatives are important for the maintenance of T-bet expression in CD4 T cells and the development of a protective Th1 response [43 ] .
The infection microenvironment: a crossroad between fungal and host factors
The above studies illustrate our understanding of key immune system mechanisms to prevent invasive A. fumigatus infections primarily in the immunocompetent host. Future challenges will include learning how this understanding of fungal resistance can be translated into the immunocompromised patient populations that acquire A. fumigatus infections. However, once germination occurs in an immunocompromised patient, the relationship between the tissue microenvironment and fungal cell metabolic activity during the course of infection is largely unappreciated, but potentially important for disease outcome and evolution of host immune responses. A better understanding of how the host microenvironment influences fungal virulence and immunomodulatory factors, as well as what factors induce changes in the infection microenvironment itself, should improve our ability to design more effective therapeutics to manage invasive aspergillosis. With this in mind, we review recent advances in our understanding of the fungal response to the infection microenvironment encountered by A. fumigatus during colonization and invasive growth in immunocompromised hosts.
Fungal secondary metabolism
A unique aspect of A. fumigatus metabolism is the production of bioactive secondary metabolites, which are typically dispensable for completion of the fungal life cycle [53] . The most studied A. fumigatus secondary metabolite is the epipolythiodioxopiperazine gliotoxin [54] [55] [56] [57] that is produced in murine models of invasive aspergillosis [58, 59] . The role of gliotoxin in invasive pulmonary aspergillosis (IPA) seems to be host microenvironment dependent, with the key factor being the method of immunosuppression. In murine models of IPA that utilize cyclophosphamide for neutrophil depletion, gliotoxin production was found to be dispensable for disease development [59] [60] [61] [62] . However, in murine models that utilize corticosteroids for immunosuppression, gliotoxin was found to be a critical factor for disease development [62, 63] . Although the exact mechanism for gliotoxin's differential role in Aspergillus virulence is unknown, its ability to induce apoptosis in neutrophils is thought to be a primary mode of action [62] [63] [64] . The massive myeloid cell depletion that occurs when cyclophosphamide is used as the immunosuppressant may mitigate any effects of gliotoxin on these target cells that are largely absent from the infection site.
In addition to gliotoxin's direct effect on neutrophils, recent data suggest an in-vivo link between secondary metabolite production and inhibition of host angiogenesis, as the A. fumigatus laeA null mutant that is deficient in secondary metabolite production does not inhibit angiogenesis to the same degree as the wild-type strain [65 ] . Both gliotoxin and fumagillin are candidate secondary metabolites that may mediate the LaeAdependent effect on host angiogenesis. Intriguingly, inhibition of host angiogenesis likely results in significant localized tissue hypoxia [66] . Deficiency of the LaeA transcriptional regulator also impacts the composition of the fungal cell wall, resulting in a diminished hydrophobic layer and enhanced phagocytosis of DlaeA spores by neutrophils [67] .
Hypoxia adaptation
As mentioned, oxygen availability is an important feature of the infection microenvironment that is not well understood. Oxygen is a critical molecule for both host and pathogen cell metabolism and its absence places a significant stress on most eukaryotic cells. Recent studies confirm that in three immunologically distinct murine models of IPA (neutropenic, corticosteroid, and chronic granulomatous disease), hypoxia (O 2 1.5%) occurs at sites of A. fumigatus invasive growth in the lung [68] . Importantly, the ability to overcome hypoxia appears to be a requirement for lethal disease, as SrbA, a fungal transcription factor in the sterol regulatory element-binding protein family, is required for A. fumigatus growth under hypoxia and for lethal invasive disease in multiple murine models of IPA [69] . Ongoing studies are exploring the mechanisms of SrbA-dependent hypoxia growth and its relation to invasive disease.
The presence of hypoxia at the site of infection is also likely to have a significant effect on the expression and composition of the fungal cell wall. In the yeast Saccharomyces cerevisiae, low-oxygen environments stimulate cell-wall remodeling that results in increased exposure or production of the DAN/TIR mannoproteins [70] [71] [72] .
Although whole-genome gene expression studies reveal significant transcriptional changes in A. fumigatus cell-wall biosynthesis genes in response to hypoxia (B. Barker, R.A. Cramer, unpublished observation), the functional significance and exact nature of these changes remains to be elucidated, specifically in the context of clinically relevant immunosuppression regimens.
Immunopharmacologic effects
The presence of antifungal drugs used to treat A. fumigatus infections may also alter the infection microenvironment by affecting fungal metabolism and subsequent host responses. Echinocandin drugs, b-(1,3) glucan synthase inhibitors, alter the surface content of b-glucan on A. fumigatus hyphae resulting in enhanced macrophage and neutrophil inflammatory responses via a Dectin-1dependent mechanism [73, 74] . In a systemic candidiasis model, echinocandin-dependent b-(1,3)-glucan exposure occurs in infected tissues [75] . Thus, echinocandin drugs may act in part via an immunopharmacologic mechanism to benefit the host, as they fail to inhibit A. fumigatus growth completely at any concentration. The effects of amphotericin B on the immune system are also an active area of investigation [76] .
Conclusion
The past several years have witnessed significant advances in our understanding of host defense mechanisms against A. fumigatus and of fungal attributes that facilitate growth in hostile tissue microenvironments. Several of these findings have important clinical implications for patient care. First, dissection of host pathways involved in fungal recognition and killing has led to advances in the field of immunogenetics and the recognition of genetic risk for invasive aspergillosis in the context of bone marrow transplantation [77] . An important area of research is to incorporate these findings into patient care, for example, in prophylaxis strategies and allograft selection when multiple donors are available. Second, the recognition that monocytes, dendritic cells, and NK cells can act in host defense in neutropenic hosts opens new research directions for myeloid reconstitution and adoptive transfer strategies. Third, improved understanding of molecular cues that underlie CD4 T-cell differentiation has implications for modulating allergenic responses, as exemplified by the link between vitamin D levels and Th2 responses in ABPA patients [46 ] . Fourth, research on the influence of the infection microenvironment on fungal metabolism may lead to new drug targets and a better understanding of which immunomodulatory techniques may be therapeutically viable. These areas of research provide fertile ground to build on improvements in clinical outcomes [78] and to reduce Aspergillus-related morbidity and mortality.
